Live symbol workspace

XLV market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $146.81

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$139.47

Resistance

$154.15

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$146.81

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for XLV skewed bullish (7 of 14 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

▼ 8.8 pts vs previous week

Avg confidence across 28 calls in the last 7 days

What sources say

Bullish 7 articles

3 Healthcare Stocks with Open Questions

Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?

Neutral 5 articles

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

Bearish 2 articles

State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio?

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

XLV News Intelligence (32 articles)

AI-curated news influencing XLV price, sentiment, and trend

Explore All XLV News with AI Analysis

Economy

3 weeks, 3 days ago

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?

State Street's concentrated 60-stock approach outpaced Fidelity's broader 365-holding fund over five years, though both charge identical 0.08% fees.

Impact on XLV: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

3 weeks, 4 days ago

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

PINK outperformed XLV by 8.7 percentage points over one year, but carries higher fees and volatility. XLV offers lower costs …

Impact on XLV: May pressure downward momentum

Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

4 weeks, 2 days ago

Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?

FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approach offers lower costs and steadier …

Impact on XLV: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Regulation

1 month ago

The Regulatory Costberg is melting—or is it? An update on Trump’s “one-in, ten-out” initiative - Competitive Enterprise Institute

The Regulatory Costberg is melting—or is it? An update on Trump’s “one-in, ten-out” initiative  Competitive Enterprise Institute

Impact on XLV: The potential reduction in regulatory costs could positively impact sectors with high …

The article discusses the status of Trump's 'one-in, ten-out' regulatory initiative, which aims to reduce … Medium (50%)

View full analysis →

Google News 50% confidence

Economy

1 month, 1 week ago

Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?

IBBQ surged 54.5% in one year but carries deeper drawdowns. XLV offers broader diversification, lower costs, and double dividend yield …

Impact on XLV: Potentially positive price action expected

Financial market analysis indicating bullish sentiment based on current trends. High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

1 month, 3 weeks ago

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical …

Impact on XLV: The 7.6% gain in healthcare stocks over the past six months indicates …

Healthcare stocks have gained 7.6% over the past six months, mirroring the S&P 500, driven … High (70%)

View full analysis →

Yahoo Finance 70% confidence